We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Dried Cerebrospinal Fluid Spots Detect Anti-Japanese Encephalitis IgM

By LabMedica International staff writers
Posted on 29 Mar 2016
The use of filter paper as a simple, inexpensive tool for storage and transportation of blood, “Dried Blood Spots” or Guthrie cards, for diagnostic assays is well-established, but in contrast, there are a paucity of diagnostic evaluations of dried cerebrospinal fluid spots.

Japanese encephalitis virus (JEV) infection is widespread in Asia, and primarily affects children in poor, rural areas and the virus spreads to the brain and spinal cord resulting in significant death and disability. More...
Diagnosis requires testing for the immune response “antibody” specific to JEV in the cerebrospinal fluid (CSF) that surrounds the brain and spinal cord.

An international team of scientists led by those at the London School of Hygiene and Tropical Medicine (UK) developed a dried CSF spot protocol to evaluate its diagnostic performance using the World Health Organization (Geneva, Switzerland) recommended anti-JEV immunoglobulin M (IgM) antibody capture enzyme-linked immunosorbent assay (JEV MAC-ELISA). Patient CSF and serum samples were collected at three hospitals in Laos from 2009 to 2015.

The investigators employed a novel technique using a pre-cut circle of cellulose-cotton paper. Samples were dried on the pre-cut filter paper and then left for 30 days at room temperature. Two types of filter paper were chosen, and utilized in all the studies: the Whatman 903 Protein Saver Card (903) and the 3MM Chr Blotting paper (3MM) (GE Healthcare Life Sciences; UK). The commercial JEV MAC-ELISA assay used was is the JE Detect IgM Capture ELISA (Inbios; Seattle, WA, USA). This assay measures the Optical Density (OD) of each sample with JEV Recombinant Antigen, JERA, compared to Normal Control Antigen (NCA) to adjust for background nonspecific reactivity.

There were a total of 132 samples containing sufficient fluid volume for testing. When tested for the presence of viral antibodies 34 dried samples and 38 neat samples tested positive, with overall agreement of 92.4%. Compared with neat non-dried samples the dried spots showed 81.6% positive agreement and 96.8% negative agreement. The saturation of filter paper has potential use in the wider context of pathogen detection, including dried spots for detecting other analytes in CSF, and other body fluids. The authors concluded that the novel design of pre-cut filter paper saturated with CSF could provide a useful tool for JEV diagnostics in settings with limited laboratory access. It has the potential to improve national JEV surveillance and inform vaccination policies.

Tehmina Bharucha, PhD, the lead author of the study, said, “This novel method for saturating dried cerebrospinal fluid spots has the potential to enhance our knowledge of Japanese encephalitis virus epidemiology, and inform health policies where they are most needed. It could also be transferred for use in diagnosing other infectious diseases, including using other body fluid samples.” The study was published on March 17, 2016, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

London School of Hygiene and Tropical Medicine
World Health Organization
GE Healthcare Life Sciences



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Gold Member
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Scout\'s patented molecular technology delivers results matching high-complexity PCR 99% of the time (Photo courtesy of Scout Health)

STI Molecular Test Delivers Rapid POC Results for Treatment Guidance

An affordable, rapid molecular diagnostic for sexually transmitted infections (STIs) has the potential to be globally relevant, particularly in resource-limited settings where rapid, point-of-care results... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.